Pinnacle ATX

Pinnacle Clinical Research is a premier clinical research organization and site network specializing in the study of liver disease, with a particular focus on nonalcoholic steatohepatitis (NASH) and metabolic dysfunction-associated steatohepatitis (MASH). Based in Texas with major centers in San Antonio and Austin, the company serves as a leading site for Phase 1 through Phase 4 clinical trials, partnering with global pharmaceutical and biotechnology companies. Pinnacle is recognized for its high-volume screening programs and its expertise in advanced diagnostic modalities such as FibroScan and MRI-PDFF. The organization plays a critical role in the development of therapeutic interventions for fatty liver disease and related metabolic disorders.